NR4A1 and breast carcinoma: Analysis of both U133A expression dataset from 2635 breast cancer and 91 normal breast tissue specimens and U133Plus2 expression dataset from 1513 breast cancer and 241 breast normal tissue specimens revealed that NR4A1 expression was significantly downregulated in breast cancers versus normal breast tissues (Figure 1A).